As an example, in triple damaging breast cancer (TNBC),25 and in hepatocellular carcinoma,26 DNA methylation profiles have aided to your identification of distinctive subgroups with clinical relevance. Epigenetic techniques have also aided to the development of prognostic exams to evaluate the sensitivity of cancer cells to unique medicine.27 We https://directivepublications.org/world-journal-of-clinical-cancer-research/